1FVO image
Deposition Date 2000-09-20
Release Date 2001-04-04
Last Version Date 2024-05-22
Entry Detail
PDB ID:
1FVO
Keywords:
Title:
CRYSTAL STRUCTURE OF HUMAN ORNITHINE TRANSCARBAMYLASE COMPLEXED WITH CARBAMOYL PHOSPHATE
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
I 2 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:ORNITHINE TRANSCARBAMYLASE
Gene (Uniprot):OTC
Chain IDs:A, B
Chain Length:321
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Human ornithine transcarbamylase: crystallographic insights into substrate recognition and conformational changes.
Biochem.J. 354 501 509 (2001)
PMID: 11237854 DOI: 10.1042/0264-6021:3540501

Abstact

Two crystal structures of human ornithine transcarbamylase (OTCase) complexed with the substrate carbamoyl phosphate (CP) have been solved. One structure, whose crystals were prepared by substituting N-phosphonacetyl-L-ornithine (PALO) liganded crystals with CP, has been refined at 2.4 A (1 A=0.1 nm) resolution to a crystallographic R factor of 18.4%. The second structure, whose crystals were prepared by co-crystallization with CP, has been refined at 2.6 A resolution to a crystallographic R factor of 20.2%. These structures provide important new insights into substrate recognition and ligand-induced conformational changes. Comparison of these structures with the structures of OTCase complexed with the bisubstrate analogue PALO or CP and L-norvaline reveals that binding of the first substrate, CP, induces a global conformational change involving relative domain movement, whereas the binding of the second substrate brings the flexible SMG loop, which is equivalent to the 240s loop in aspartate transcarbamylase, into the active site. The model reveals structural features that define the substrate specificity of the enzyme and that regulate the order of binding and release of products.

Legend

Protein

Chemical

Disease

Primary Citation of related structures